Intel (Santa Clara, Calif.) has announced that it will be expanding availability of the Intel Health Guide in Europe and is working with industry partners in France, Germany, Spain and The Netherlands to bring localized versions of the Intel Health Guide to market in the coming year. The announcement was made at the World Congress for Information Technology in Amsterdam.
The Intel Health Guide combines an in-home patient device with an online interface to allow physicians to remotely and securely monitor patients in their homes, addressing challenges of chronic conditions for patients. Chronic conditions currently account for 70 percent of total health expenditure in Europe.
The Intel Health Guide is already commercially available in the United Kingdom, United States, Ireland and Australia. Intel is working on a pilot project with the Martini Hospital and CurIT in Groningen to use the Intel Health Guide for pregnant women with diabetes.
